UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE l3D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
KINDRED HEALTHCARE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.25 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
494580103
--------------------------------------------------------------------------------
(CUSIP Number)
with a copy to:
Stephen Feinberg Robert G. Minion, Esq.
299 Park Avenue Lowenstein Sandler PC
22nd Floor 65 Livingston Avenue
New York, New York 10171 Roseland, New Jersey 07068
(212) 421-2600 (973) 597-2424
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
September 10, 2003
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule l3G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Cusip No. 494580103
--------------------------------------------------------------------------------
1) Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only):
Stephen Feinberg
--------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a) Not
(b) Applicable
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Source of Funds (See Instructions): WC
--------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e): Not Applicable
--------------------------------------------------------------------------------
6) Citizenship or Place of Organization: United States
--------------------------------------------------------------------------------
Number of 7) Sole Voting Power: *
------------------------------------
Shares Beneficially 8) Shared Voting Power: *
------------------------------------
Owned by
Each Reporting 9) Sole Dispositive Power: *
------------------------------------
Person With 10) Shared Dispositive Power: *
------------------------------------
--------------------------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person:
1,622,721*
--------------------------------------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions): Not Applicable
--------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11): 9.1%*
--------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions): IA, IN
--------------------------------------------------------------------------------
* Cerberus Partners, L.P., a Delaware limited partnership ("Cerberus"), is the
holder of 20,225 shares of the common stock, par value $0.25 per share (the
"Shares"), of Kindred Healthcare, Inc. (the "Company"), Cerberus Institutional
Partners, L.P., a Delaware limited partnership ("Institutional"), is the holder
of 294,384 Shares, Cerberus International, Ltd., a corporation organized under
the laws of the Bahamas ("International"), is the holder of 873,486 Shares and
various other private investment funds (the "Funds") own in the aggregate
434,626 Shares. Stephen Feinberg possesses sole power to vote and direct the
disposition of all securities of the Company owned by each of Cerberus,
Institutional, International and the Funds. Thus, for the purposes of Reg.
Section 240.13d-3, Stephen Feinberg is deemed to beneficially own 1,622,721
Shares, or 9.1% of those deemed issued and outstanding. See Item 5 of this
Amendment No. 5 to Schedule 13D for further information.
Item 2. Identity and Background.
-----------------------
The person filing this statement is Stephen Feinberg, whose business
address is 299 Park Avenue, 22nd Floor, New York, New York 10171. Mr. Feinberg
serves as the managing member of Cerberus Associates, L.L.C., the general
partner of Cerberus Partners, L.P., a Delaware limited partnership ("Cerberus"),
and the investment manager for Cerberus Institutional, L.P., a Delaware limited
partnership ("Institutional"), Cerberus International, Ltd., a corporation
organized under the laws of the Bahamas ("International"), and various other
private investment funds (the "Funds"). Cerberus, Institutional, International
and the Funds are engaged in the investment in personal property of all kinds,
including but not limited to capital stock, depository receipts, investment
companies, mutual funds, subscriptions, warrants, bonds, notes, debentures,
options and other securities of whatever kind and nature. Mr. Feinberg also
provides investment management and other services for various other third
parties.
Mr. Feinberg has never been convicted in any criminal proceeding
(excluding traffic violations or similar misdemeanors), nor has he been a party
to any civil proceeding commenced before a judicial or administrative body of
competent jurisdiction as a result of which he was or is now subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws. Mr. Feinberg is a citizen of the
United States.
Item 5. Interest in Securities of the Issuer.
------------------------------------
Based upon the Company's Quarterly Report on Form 10-Q for the
quarterly period ended June 30, 2003, as of July 31, 2003 there were 17,862,454
Shares issued and outstanding. As of September 10, 2003, Cerberus is the holder
of 20,225 Shares, Institutional is the holder of 294,384 Shares, International
is the holder of 873,486 Shares and the Funds in the aggregate hold 434,626
Shares. Mr. Feinberg possesses sole power to vote and direct the disposition of
all securities of the Company owned by each of Cerberus, Institutional,
International and the Funds. Thus, for the purposes of Reg. Section 240.13d-3,
Stephen Feinberg is deemed to beneficially own 1,622,721 Shares, or 9.1% of
those deemed issued and outstanding.
The following table details the transactions for the sixty days prior
to September 10, 2003, in Shares, or securities convertible into, exercisable
for or exchangeable for Shares, by Mr. Feinberg or any other person or entity
controlled by him or any person or entity for which he possesses voting or
investment control over the securities thereof (each of which were effected in
an ordinary brokerage transaction):
I. Cerberus
-----------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
August 18, 2003 1,300 $29.16
September 9, 2003 900 $31.79
September 10, 2003 1,850 $31.69
II. Institutional
-----------------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
August 18, 2003 17,900 $29.16
September 9, 2003 13,000 $31.79
September 10, 2003 27,600 $31.69
III. International
------------------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
August 18, 2003 54,000 $29.16
September 9, 2003 39,000 $31.79
September 10, 2003 80,250 $31.69
IV. The Funds
-------------
(Purchases)
NONE
(Sales)
Date Quantity Price
---- -------- -----
August 18, 2003 26,800 $29.16
September 9, 2003 19,200 $31.79
September 10, 2003 39,300 $31.69
Signature
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
September 11, 2003
/s/ Stephen Feinberg
--------------------------------------
Stephen Feinberg, in his capacity
as the managing member of Cerberus
Associates, L.L.C., the general
partner of Cerberus Partners, L.P.,
and the investment manager for
Cerberus Institutional Partners, L.P.,
Cerberus International, Ltd. and the
Funds
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).